In an email to staff on Thursday Janet Woodcock, director of the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER), announced that the center's formal dispute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results